Literature DB >> 12521552

Fetal cells in maternal blood.

Lee P Shulman1.   

Abstract

Fetal cells in maternal blood represent the future of prenatal screening and diagnosis. The possibility of analyzing fetal cells recovered from maternal blood could provide screening and diagnostic protocols characterized by high sensitivity and specificity with no direct risk to the developing fetus. Years of investigation have thus far not led to the development of reliable and consistent protocols; nonetheless, fetal cell recovery promises to be an attractive addition to noninvasive prenatal diagnosis.

Mesh:

Year:  2003        PMID: 12521552

Source DB:  PubMed          Journal:  Curr Womens Health Rep        ISSN: 1534-5874


  1 in total

1.  SRY sequence in maternal plasma: Implications for non-invasive prenatal diagnosis: First report from India.

Authors:  Edna D'Souza; Sona Nair; Anita Nadkarni; Kanjaksha Ghosh; Roshan B Colah
Journal:  Indian J Hum Genet       Date:  2012-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.